Saved
AlignMap's Archive on Mar 17, 2008
19 Views
1 Member
Description
Reminder that "adherence" is not always seen as being motivated by altruistic impulses and that alliances with Pharma may be viewed, justifiably or not, as collusion against the best interests of the patient.
Clipping
The bill would allow companies like Adheris, the bill sponsor, to access patients' prescription drug purchases, putatively only for the purpose of communicating with patients to increase "adherence" to the scheduled regimen. But it is clearly, for the drug companies that pay Adheris, a direct marketing tool. Adheris is likely to directly or indirectly encourage a patient to stay on a branded medication, even if a cheaper generic is available.